Daiichi and Ranbaxy to tie the knot
The largest Indian drugmaker is hooking up with a Japanese pharmaceutical firm.
Ranbaxy, the largest drug company in India, has agreed to sell a majority stake of its firm to the Japanese drugmaker Daiichi Sankyo for up to $4.6 billion. The deal will vault Daiichi into the top ranks of generic companies in this country. Industry insiders believe this move makes sense when generic drug sales are growing like topsy in the United States while brand drug sales have slowed.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
